An overview of Metrion Biosciences


Video title
An overview of Metrion Biosciences

Metrion Biosciences’ CEO Dr Andrew Southan presents an overview of Metrion Biosciences, highlighting the company’s vision, expertise and services.


Andrew Southan PhD 1
Dr Andrew Southan
Chief Executive Officer
Metrion Biosciences

Dr Andrew Southan

Andy has over 25 years’ experience in life science research, with a PhD in Pharmacology from the University of London (UK). Following a move to industry, Andy worked as a brain slice electrophysiologist supporting ion channel-based CNS programmes at Wyeth (UK), before moving to Imperial College London where he published the first patch-clamp recordings from cerebellar inhibitory nerve terminals. Before joining Metrion, Andy also held positions at CeNeS Pharmaceuticals, Ionix Pharmaceuticals, BioFocus and Charles River, amassing 14 years’ experience within the CRO sector.

Wave Background thinner 01 1
Metrion Ion Channel Screening Icon 01

Let’s work together

What are your specific ion channel and assay needs?

If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.